What to know about Trump’s new CDC director pick

The latest stories trending on MedCity News.

Editor's Pick

Top Story 6 Things to Know About Trump's New CDC Director Pick President Donald Trump selected Susan Monarez — the current acting director of the Centers for Disease Control and Prevention — to lead the agency going forward. This nomination replaces one that the White House withdrew on March 13, after it became clear that physician and former Republican congressman Dave Weldon would not receive enough Senate votes to be confirmed. Sponsored How to Improve Employee Benefits While Reducing Insurance Costs Presented by The Difference Card Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost. Learn more. Dr. Jesse Ehrenfeld, Immediate Past President of American Medical Association will be Speaking at INVEST 2025! Jesse will be part of the panel, "What are Health Systems' Strategic Priorities in the Post-Pandemic Era?", discussing how hospitals are navigating the new normal—whatever that may be. With the immediacy of the crisis behind us, how are health systems working toward the Quadruple Aim in healthcare? Learn from top industry leaders as they share their insights. Register For INVEST Chicago Now

Featured News

Help Shape the Future of Healthcare Benefits Strategy [Sponsored] Contribute to the 2025 Benefit Consultant Sentiment Index! Anne Wojcicki Had a Fully Financed Plan to Take 23andMe Private. Then It Fell Apart. A month before 23andMe's bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing company private. The financing fell apart, and a series of alternative proposals by Wojcicki did not result in a deal. PBGH Offers Advisory Services to Support Employers' Fiduciary Responsibilities PBGH is now offering its advisory services to any purchaser. These services help employers fulfill their fiduciary responsibility, understand their data and more. Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. How Health Systems Can Thrive in Navigating the Specialty Pharmacy Landscape Specialty pharmacies must meet complex requirements, introducing administrative requirements that can be challenging for health systems to manage internally. Here some strategies that can be employed.

Video   23andMe Files for Bankruptcy: How to Delete your Data 23andMe filed for bankruptcy on Sunday following years of decreased demand for its genetic testing product. Former users are rushing to delete their data from the company's platform — which is a task that may require some patience.

Sponsored Everything You Need to Know About Sterilization Cases and Their Role in Healthcare Presented by Jewel Precision Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers. Learn More

Resources

Debunked Episode 13: Will the Real AI Please Stand Up? The latest episode of Debunked, with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, talked about the many iterations of AI, NIH funding cuts, and a deal to sell Walgreens. Watch Now!

MedCity News • PO Box 901 • New York, NY unsubscribe